Manning & Napier Group, LLC Gilead Sciences, Inc. Transaction History

Manning & Napier Group, LLC

$8.76 Billion
Q1 2024

A detailed history of Manning & Napier Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Manning & Napier Group, LLC holds 307,930 shares of GILD stock, worth $27.7 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

307,930

Previous 334,340 7.9%

Holding current value

$27.7 Million

Previous $27.1 Million 16.72%

% of portfolio

0.26%

Previous 0.32%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$71.58 - $87.29 $1.89 Million - $2.31 Million	-26,410 Reduced 7.9%	307,930 $22.6 Million
Q4 2023 Jan 19, 2024	SELL	$73.27 - $83.09 $4.21 Million - $4.78 Million	-57,475 Reduced 14.67%	334,340 $27.1 Million
Q3 2023 Oct 20, 2023	SELL	$73.94 - $80.67 $396,244 - $432,310	-5,359 Reduced 1.35%	391,815 $29.4 Million
Q2 2023 Jul 26, 2023	BUY	$76.01 - $86.7 $1.75 Million - $2 Million	23,077 Added 6.17%	397,174 $30.6 Million
Q1 2023 Apr 17, 2023	SELL	$77.31 - $88.08 $53,498 - $60,951	-692 Reduced 0.18%	374,097 $31 Million
Q4 2022 Jan 26, 2023	SELL	$62.32 - $89.47 $258,877 - $371,658	-4,154 Reduced 1.1%	374,789 $0
Q3 2022 Oct 18, 2022	SELL	$59.54 - $68.01 $301,629 - $344,538	-5,066 Reduced 1.32%	378,943 $23.4 Million
Q2 2022 Jul 12, 2022	SELL	$57.72 - $65.01 $2.39 Million - $2.69 Million	-41,336 Reduced 9.72%	384,009 $23.7 Million
Q1 2022 Apr 19, 2022	SELL	$57.92 - $72.58 $1.66 Million - $2.08 Million	-28,726 Reduced 6.33%	425,345 $25.3 Million
Q4 2021 Jan 27, 2022	SELL	$64.88 - $73.64 $1.55 Million - $1.76 Million	-23,939 Reduced 5.01%	454,071 $33 Million
Q3 2021 Oct 14, 2021	SELL	$67.69 - $73.03 $551,470 - $594,975	-8,147 Reduced 1.68%	478,010 $33.4 Million
Q2 2021 Jul 19, 2021	BUY	$63.47 - $69.35 $4.29 Million - $4.69 Million	67,578 Added 16.14%	486,157 $33.5 Million
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $582,660 - $664,815	9,711 Added 2.38%	418,579 $27.1 Million
Q4 2020 Jan 20, 2021	SELL	$56.65 - $64.55 $1.68 Million - $1.91 Million	-29,662 Reduced 6.76%	408,868 $23.8 Million
Q3 2020 Oct 29, 2020	SELL	$62.1 - $78.08 $192,510 - $242,048	-3,100 Reduced 0.7%	438,530 $27.7 Million
Q2 2020 Jul 10, 2020	BUY	$72.34 - $84.0 $1.95 Million - $2.26 Million	26,953 Added 6.5%	441,630 $34 Million
Q1 2020 Apr 13, 2020	SELL	$62.63 - $80.22 $2.37 Million - $3.03 Million	-37,816 Reduced 8.36%	414,677 $31 Million
Q4 2019 Jan 10, 2020	BUY	$61.62 - $67.78 $2.78 Million - $3.06 Million	45,168 Added 11.09%	452,493 $29.4 Million
Q3 2019 Oct 10, 2019	BUY	$62.51 - $69.0 $183,029 - $202,032	2,928 Added 0.72%	407,325 $25.8 Million
Q2 2019 Jul 24, 2019	BUY	$61.87 - $69.38 $3.9 Million - $4.37 Million	62,980 Added 18.45%	404,397 $27.3 Million
Q1 2019 Apr 10, 2019	BUY	$62.53 - $70.05 $4.25 Million - $4.76 Million	67,924 Added 24.84%	341,417 $22.2 Million
Q4 2018 Jan 24, 2019	BUY	$60.54 - $79.0 $1.5 Million - $1.96 Million	24,830 Added 9.99%	273,493 $17.1 Million
Q3 2018 Oct 10, 2018	BUY	$71.28 - $78.92 $1.07 Million - $1.19 Million	15,062 Added 6.45%	248,663 $19.2 Million
Q2 2018 Jul 13, 2018	BUY	$64.88 - $75.68 $1.34 Million - $1.56 Million	20,659 Added 9.7%	233,601 $16.5 Million
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $2.87 Million - $3.5 Million	39,383 Added 22.69%	212,942 $16.1 Million
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $12.3 Million - $14.5 Million	173,559	173,559 $12.4 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.

Account

Manning & Napier Group, LLC Gilead Sciences, Inc. Transaction History